Standard BioToolsLAB

那斯達克 · USD
0.90
0.00
(+0.24%)
盤中 04/27 11:38 (UTC+8)
04/27 11:38 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.25
  • 0.28
  • 0.46
  • 0.37
  • 0.45
  • 1.08
  • 0.41
  • 0.01
  • 0.20
  • 0.24
icon
  • -8.31
  • 11.12
  • 61.56
  • -18.30
  • 20.87
  • 140.61
  • -12.68
  • -97.09
  • 1544.41
  • 21.70
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
營業收入淨額
23,795
19,552
1,189
40,795
108,201
44,969
37,205
45,540
28,188
25,367
營業成本
12,41310,068-74721,05457,46521,70822,29721,35214,83114,157
營業毛利
11,382
9,484
1,936
19,741
50,736
23,261
14,908
24,188
13,357
11,210
營業費用
36,02642,42221,63352,711124,56954,97965,42784,37034,74332,382
研發費用
7,9696,35633411,32840,62013,15619,22215,9806,9096,426
推銷及管理費用
25,98226,63819,57239,83183,82339,48240,45664,10626,17323,958
非經常性項目費用
2,0759,4281,7271,5521262,3415,7494,2841,6611,998
其他營業費用
----------
營業利益
-24,644
-32,938
-19,697
-32,970
-73,833
-31,718
-50,519
-60,182
-21,386
-21,172
其他收入及費用
2,618484,1196,788-4114,8983,82328,1536,0153,694
利息費用
51092572--1,033-4,5673,469
稅前純益
-22,031
-32,900
-15,587
-26,184
-74,816
-26,820
-45,663
-32,029
-19,938
-20,947
所得稅
-35,932-1,216-577-15130311855128-16250
稅後純益
19,283
-34,687
-33,459
-26,033
-34,072
-26,938
-45,718
-32,157
-19,776
-20,997
基本每股稅後盈餘(元)
0.05-0.09-0.09-0.07-0.09-0.07-0.12-0.27-0.25-0.27
稀釋每股稅後盈餘(元)
0.05-0.09-0.09-0.07-0.08-0.07-0.10-0.27-0.25-0.26
基本平均股數(千股)
385048.00382630.00380498.00378228.00374544.00371538.00372331.00294125.0079729.0079152.00
稀釋平均股數(千股)
385048.00382630.00380498.00378228.00374544.00371538.00372331.00294125.0079729.0079152.00
還原基本每股稅後盈餘(元)
0.05-0.09-0.09-0.07-0.09-0.07-0.12-0.27-0.25-0.27
還原稀釋每股稅後盈餘(元)
0.05-0.09-0.09-0.07-0.08-0.07-0.10-0.27-0.25-0.26
還原基本平均股數(千股)
385,048382,630380,498378,228374,544371,538372,331294,12579,72979,152
還原稀釋平均股數(千股)
385,048382,630380,498378,228374,544371,538372,331294,12579,72979,152
EBITDA(千元)
-15,815-34,983-30,763-22,852-30,376-24,721-44,724-29,495-10,374-12,744

大家都在看

HOT